期刊文献+

HPV16 E6和E7基因序列多态性与宫颈癌临床病理特征相关性 被引量:2

CORELATION BETWEEN THE POLYMORPHISM OF E6 AND E7 ONCOGENE OF HUMAN PAPILLOMAVIRUS TYPE 16 AND THE PATHOLOGICAL FEATURES OF CERVICAL CANCER
下载PDF
导出
摘要 目的探讨宫颈癌人乳头瘤病毒16型(HPV16)E6和E7转化基因序列多态性,及其与宫颈癌临床病理特征的相关性。方法从77例宫颈癌组织中筛选出51例HPV16阳性标本,扩增E6及E7基因,PCR产物进行序列测定。应用DNAStar生物软件进行核苷酸和氨基酸序列的分析。结果宫颈癌组织中HPV16 E6共测得6个突变位点,均为错义突变;最常见的突变位点为T178G/A(D29E),突变频率为56.00%,T178G/A突变在不同分化程度、不同分期、不同肿瘤大小及有无淋巴结转移组的分布频率差异无显著性(P>0.05)。宫颈癌组织中HPV16 E7共测得4个突变位点,2个为错义突变;最常见的突变位点为A647G(N29S),突变频率为68.09%,A647G在中分化及低分化组的突变频率分别为56.67%、88.24%,两组间突变频率差异有显著性(χ2=4.98,P<0.05);A647G在不同分期、不同肿瘤大小、有无淋巴结转移组的分布频率差异无显著性(P>0.05)。结论青岛地区HPV16 E6基因T178G/A突变与宫颈癌的发生发展无关,HPV16 E7基因A647G突变与宫颈癌的分化程度呈负相关,可以作为评估宫颈癌恶性程度的指标。 Objective To investigate the polymorphism of HPV16 transforming gene E6 and E7 and its relationship with the pathological features of patients with cervical cancer. Methods Fifty-one HPV16-positive samples were screened form tissues of 77 cases of cervical cancer,E6 and E7 genes were amplified,and sequence analysis was done for PCR products. ResultsSix mutable points of HPV16 E6 gene were identified,which were missense mutation;the most frequently seen mutable point was T178G/A,with the mutation frequency of 56.00%,which was not significantly related with the differentiation,clinical stage,tumor size and lymph node metastasis(P〉0.05).Four mutable points were identified in HPV16 E7 gene of the cancer tissues,two of which were missense mutation,the most commonly seen mutable point was A647G(N29S),with its mutation frequency of 68.09%.The frequency of A647G in moderately-differentiated and poorly-differentiated group was 56.67% and 88.24%,respectively,the difference being significant between the two groups(χ2=4.98,P〈0.05),but the differences of distribution frequency of A647G were not significant in terms of clinical stage,tumor size and lymph node metastasis(P〉0.05). ConclusionIn Qingdao areas,the mutation of HPV16 E6 T178G/A is not associated with the pathogenesis of cervical cancer,and that of HPV16 E7 A647G is negatively correlated with the degree of differentiation,which can be used as a marker for estimating the malignancy of this condition.
出处 《齐鲁医学杂志》 2011年第4期308-310,313,共4页 Medical Journal of Qilu
关键词 宫颈肿瘤 人乳头瘤病毒16 E6基因 E7基因 多态性 单核苷酸 uterine cervical neoplasms human papillomavirus 16 E6 gene E7 gene polymorphism single nucleotide
  • 相关文献

参考文献11

  • 1SEEDORF K, KRAMMER G, DURST M, et al. Human papillomavirus type 16 DNA sequence[J]. Virology, 1985, 145(1):181-185.
  • 2BONTKES H ], VAN DUIN M, DE GRUIJL T D, et al. HPV16 injection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV16 E6 se- quence variants[J]. Int J Cancer, 1998,78(2) : 166-171.
  • 3ANDERSSON S, ALEMI M, RYLANDER E, et al. Uneven distribution of HPV16 E6 prototype and variant (L83V) onto- protein in cervical neoplastic lesions[J]. Br J Cancer, 2000, 83(3) : 307-310.
  • 4STOPPLER M C, CHING K, STOPPLER H, et al. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to in- duce p53 degradation[J]. J Virol, 1996,70(10) : 6987-6993.
  • 5MATSUMOTO K, YOSHIKAWA H, NAKAGAWA S, et al. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population[J]. Cancer Lett, 2000,156(2) : 159-165.
  • 6YAMADA T, MANOS M M, PETO J, et al. Human papillo- mavirus type 16 sequence variation in cervical cancers: a worl.dwide perspeetive[J], ar Virol, 1997,71(3) :2463-2472.
  • 7ZEHBE I, WILANDER E, DELIUS H, et al. Human papil- lomavirus 16 E6 variants are more prevalent in invasive cervi- cal carcinoma than the prototype[J]. Cancer Res, 1998,58 (4) : 829-833.
  • 8PANDE S, JAIN N, PRUSTY B K, et al. Human papilloma- virus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer pa- tients in north India[J]. J Clin Microbiol, 2008, 46 (3):1060-1066.
  • 9杨英捷,赵健,廖秦平.北京地区人乳头瘤病毒16型感染及其E6/E7基因变异与宫颈病变的相关性研究[J].中华实验和临床病毒学杂志,2007,21(1):32-34. 被引量:15
  • 10张帆,丁晓华,蔡红兵,王华,陈长春,张帅.人乳头瘤病毒16型转化基因在不同阶段宫颈上皮病变组织中的分布及基因变异特点[J].中华肿瘤杂志,2010,32(2):107-110. 被引量:9

二级参考文献31

  • 1陈庆云,卞美璐,陈志华,刘军.宫颈癌癌前病变中人乳头状瘤病毒16整合状态的检测[J].中华医学杂志,2005,85(6):400-404. 被引量:13
  • 2杨英捷,赵健,李雪倩,廖秦平.2285例女性下生殖道人乳头状瘤病毒感染筛查结果分析[J].中国实用妇科与产科杂志,2006,22(6):444-445. 被引量:95
  • 3庞天云,胡新荣,戴世忠.人乳头状瘤病毒引起宫颈肿瘤的病理过程及其机制[J].广东医学院学报,2007,25(1):66-70. 被引量:5
  • 4杨英捷,赵健,廖秦平.北京地区人乳头瘤病毒16型感染及其E6/E7基因变异与宫颈病变的相关性研究[J].中华实验和临床病毒学杂志,2007,21(1):32-34. 被引量:15
  • 5Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol, 1997, 71:2463-2472.
  • 6Andersson S, Mints M, Sallstrom J, et al. The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies: a study with human papillomavirus deoxyribonucleic acid sequence analysis. Cancer Detect Prev, 2005, 29:37-41.
  • 7Hu X, Pang T, Guo Z, et al. Oncogene lineages of human papillomavirus type 16 E6, E7 and E5 in preinvasive and invasive cervical squamous cell carcinoma. J Pathol, 2001, 195:307-311.
  • 8Klaes R, Woerner SM, Ridder R, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res, 1999, 59:6132-6136.
  • 9Vinokurova S, Wentzensen N, Kraus I, et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res, 2008, 68:307-313.
  • 10Zehbe I, Wilander E, Delius H, et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Caneer Res, 1998, 58:829-833.

共引文献20

同被引文献19

  • 1谭毅,李淑玲,谢平,林婷.高危型人乳头瘤病毒联合细胞学检测原发和复发重度宫颈上皮内瘤变[J].实用医学杂志,2006,22(6):672-673. 被引量:13
  • 2高宗侠,凌斌.人乳头瘤病毒、端粒酶、染色体异常与宫颈癌关系的研究进展[J].中国临床保健杂志,2007,10(3):325-327. 被引量:11
  • 3OIKONOMOU P, MADEMTZIS I, MESSINIS I, et al. Qun titative determination of human telomerase reverse tran scriptase messenger RNA expression in premalignant cervica lesions and correlation with human papillomavirus load [J]. Human Pathology, 2006,37(2) : 135-142.
  • 4JIANG J, WEI L H, LI Y I, et al. Detection of TERC ampli- fication in cervical epithelial cells for the diagnosis of high- grade cervical lesions and invasive cancer.- a muhicenter study in China[J]. Journal of Molecular Diagnostics, 2010,12 (6):808- 817.
  • 5SAUNIER M, MONN1ER-BENOIT S, MAUNY F, et al. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma[J]. Jour nal of Clinical Microbiology, 2008,46(11) :3678- 3682.
  • 6SNIJDERS P J, VAN DUIN M, WALBOOMERS J M, et al. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepitbeliai neoplasia grade Ⅲ lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high risk human papillomavirus DNA [J]. Cancer Researt:h, 1998,58(17) :3812-3818.
  • 7LIU S.Epigeneticesadvancingpersonalizednanomedicineincancertherapy[J].AdvDrugDelivRev,2012,64(13):1532-1543.
  • 8LID,CAIJ,KUANG Y,etal.SurgicalGpathologicriskfacGtorsofpelviclymphnodemetastasisinstageⅠb1GⅡbcervicalcancer[J].ActaObstetGynecolScand,2012,91(7):802-809.
  • 9HAGELKRUYSA,SAWICKA A,RENNMAYR M,etal.ThebiologyofHDACincancer;thenuclearandepigeneticcomponents[J].HandbExpPharmacol,2011,206:13-37.
  • 10NOWICKITS,KUMMERNT,IACOBC,etal.InhibitionofuPARanduPAreducesinvasioninpapillarythyroidcarciGnomacells[J].Laryngoscope,2010,120(7):1383-1390.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部